3-26-2019 gaining momentum on the road to accessible biosimilars

Viewpoint: We need to speed up biosimilar drug approval process

Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. Biosimilars now have the potential ...
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.